Common Contracts
11 similar Underwriting Agreement contracts by Cresco Labs Inc.
UNDERWRITING AGREEMENTUnderwriting Agreement • February 23rd, 2021 • Alberta
Echelon Wealth Partners Inc. and Cantor Fitzgerald Canada Corporation (collectively, the "Lead Underwriters"), as co-lead underwriters and co-bookrunners, along with Acumen Capital Finance Partners Limited (collectively with the Lead Underwriters, the "Underwriters") hereby severally (and not jointly nor jointly and severally) offer and agree to purchase, on a "bought deal" basis from Inner Spirit Holdings Ltd. (the "Company") an aggregate of 35,720,000 units (the "Units") of the Company at a price of $0.28 per Unit (the "Purchase Price"), upon and subject to the terms and conditions set forth in this underwriting agreement (this "Agreement"), and the Company, by its acceptance hereof, agrees to issue and sell to the Underwriters all but not less than all of the Units on the Closing Date (as defined herein), at the Purchase Price, for aggregate gross proceeds of $10,001,600 (the "Offering").
UNDERWRITING AGREEMENTUnderwriting Agreement • January 18th, 2021 • Ontario
Beacon Securities Limited (“Beacon”), as co-lead underwriter and co-bookrunner, together with Canaccord Genuity Corp. as co-lead underwriter and co-bookrunner (collectively, with Beacon, the “Underwriters” and, individually, an “Underwriter”) hereby severally, and not jointly and severally, in their respective percentages set out in Section 19 below, offer and agree to purchase, on a “bought deal” basis, in the Qualifying Jurisdictions (as defined below) and the other jurisdictions contemplated herein, including the United States, from Planet 13 Holdings Inc. (the “Company”), and the Company hereby agrees to issue and sell to the Underwriters, an aggregate of 8,575,000 units (the “Initial Units”) of the Company, at the purchase price of $7.00 per Initial Unit (the “Issue Price”), for aggregate gross proceeds of $60,025,500, upon and subject to the terms and conditions contained herein (the “Offering”). Each Initial Unit shall consist of one common share in the capital of the Company (e
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • January 13th, 2021 • Cresco Labs Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2020 • Ontario
Canaccord Genuity Corp. (“Canaccord”), as co-lead underwriter and co-bookrunner, together with Beacon Securities Limited as co-lead underwriter and co-bookrunner (collectively, with Canaccord, the “Underwriters” and, individually, an “Underwriter”) hereby severally, and not jointly and severally, in their respective percentages set out in Section 19 below, offer and agree to purchase, on a “bought deal” basis, in the Qualifying Jurisdictions (as defined below) and the other jurisdictions contemplated herein, including the United States, from Planet 13 Holdings Inc. (the “Company”), and the Company hereby agrees to issue and sell to the Underwriters, an aggregate of 5,825,000 units (the “Initial Units”) of the Company, at the purchase price of $4.30 per Initial Unit (the “Issue Price”), for aggregate gross proceeds of $25,047,500, upon and subject to the terms and conditions contained herein (the “Offering”). Each Initial Unit shall consist of one common share in the capital of the Comp
UNDERWRITING AGREEMENTUnderwriting Agreement • August 26th, 2020
Terms used in this certificate have the meanings given to them in the Underwriting Agreement, including Schedule “A” thereto, unless otherwise defined herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • August 26th, 2020 • Ontario
Beacon Securities Limited (“Beacon”), as co-lead underwriter and co-bookrunner, together with Canaccord Genuity Corp. as co-lead underwriter and co-bookrunner (collectively, with Beacon, the “Underwriters” and, individually, an “Underwriter”) hereby severally, and not jointly and severally, in their respective percentages set out in Section 19 below, offer and agree to purchase, on a “bought deal” basis, in the Qualifying Jurisdictions (as defined below) and the other jurisdictions contemplated herein, including the United States, from Planet 13 Holdings Inc. (the “Company”), and the Company hereby agrees to issue and sell to the Underwriters, an aggregate of 5,410,000 units (the “Initial Units”) of the Company, at the purchase price of $3.70 per Initial Unit (the “Issue Price”), for aggregate gross proceeds of $20,017,000, upon and subject to the terms and conditions contained herein (the “Offering”). Each Initial Unit shall consist of one common share in the capital of the Company (e
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 2019 • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2018 • Ontario
Beacon Securities Limited (“Beacon”), as lead underwriter (the “Lead Underwriter”) and sole bookrunner, together with Canaccord Genuity Corp. and Cormark Securities Inc. (collectively, with the Lead Underwriter, the “Underwriters” and, individually, an “Underwriter”) hereby severally, and not jointly and severally, in their respective percentages set out in Section 19 below, offer and agree to purchase, on a “bought deal” basis, in the Qualifying Jurisdictions (as defined below) and the other jurisdictions contemplated herein, including the United States, from Planet 13 Holdings Inc. (the “Company”), and the Company hereby agrees to issue and sell to the Underwriters, an aggregate of 8,335,000 units (the “Initial Units”) of the Company, at the purchase price of $3.00 per Initial Unit (the “Issue Price”), for aggregate gross proceeds of $25,005,000, upon and subject to the terms and conditions contained herein (the “Offering”). Each Initial Unit shall consist of one common share in the
UNDERWRITING AGREEMENTUnderwriting Agreement • October 1st, 2018 • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • July 18th, 2018 • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • February 24th, 2014
We understand that Concordia Healthcare Corp. (the “Company”) intends to sell 5,000,000 Common Shares (as defined herein) (the “Initial Shares”) at a price of $11.75 per Common Share (the “Offering Price”) and, at the option of the Underwriters (as defined herein), up to an aggregate of 750,000 additional Common Shares (the “Additional Shares”) at the Offering Price (the “Over-Allotment Option”). The Initial Shares and any Additional Shares sold upon exercise of the Over-Allotment Option, in accordance with Section 14 - of this underwriting agreement (the “Agreement”), are collectively referred to as the “Offered Shares”. The offer and sale of the Initial Shares and the offer and sale of the Additional Shares, if any, is collectively referred to as the “Offering”.
